Where can I learn more about this study?
You can find more information about this study on the websites listed below. When a full report
of the study results is available, it also can be found here.
X www.clinicaltrials.gov. Once you are on the website, type “NCT03170271”
into the search box and click “Search”.
X http://www.clinicaltrialsregister.eu. Once you are on the website, click “Home and
Search”, then type “2017-001040-35” in the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com. Once you are on the website, type “D3250C00045”
into the search box, and click “Find a Study”.
Full Study Title: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled,
Phase IIIb Study to Evaluate the Safety and Efficacy of Benralizumab 30 mg sc in Patients with
Severe Asthma Uncontrolled on Standard of Care Treatment (ANDHI)
AstraZeneca Protocol Number: D3250C00045
National Clinical Trials Number: NCT03170271
EudraCT Number: 2017-001040-35
AstraZeneca sponsored this study and has its headquarters in Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important
health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_11_19
12 | Clinical Study Results